000 | 01436 a2200445 4500 | ||
---|---|---|---|
005 | 20250513201153.0 | ||
264 | 0 | _c20000127 | |
008 | 200001s 0 0 eng d | ||
022 | _a0172-6390 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKrastev, Z | |
245 | 0 | 0 |
_aChronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study. _h[electronic resource] |
260 |
_bHepato-gastroenterology _c |
||
300 |
_a3184-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlanine Transaminase _xblood |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aDNA, Viral _xanalysis |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHepatitis B Antibodies _ximmunology |
650 | 0 | 4 |
_aHepatitis B e Antigens _ximmunology |
650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
650 | 0 | 4 |
_aHepatitis B, Chronic _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLevamisole _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aViremia _xdrug therapy |
700 | 1 | _aJelev, D | |
700 | 1 | _aAntonov, K | |
700 | 1 | _aAlagozian, V | |
700 | 1 | _aKotzev, I | |
773 | 0 |
_tHepato-gastroenterology _gvol. 46 _gno. 30 _gp. 3184-8 |
|
999 |
_c10581652 _d10581652 |